Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Psychopharmacology|July 10, 2001
Central effects of urotensin-II following ICV administration in ratsJ Gartlon, F Parker, D C Harrison, et al.
Psychopharmacology|February 24, 2001
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivityD N Jones, J Gartlon, F Parker, et al.
British Journal of Pharmacology|May 24, 2000
Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonistJ J Hagan, G W Price, P Jeffrey, et al.
Molecular Psychiatry|March 4, 2009
Analysis of gene expression in two large schizophrenia cohorts identifies multiple changes associated with nerve terminal functionP R Maycox, F Kelly, A Taylor, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1999
Orexin A activates locus coeruleus cell firing and increases arousal in the ratJ J Hagan, R A Leslie, S Patel, et al.
British Journal of Pharmacology|May 6, 2008
Characterization of a CNS penetrant, selective M1 muscarinic receptor agonist, 77-LH-28-1C J Langmead, N E Austin, C L Branch, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Pageof 8